MARKET

LTRN

LTRN

Lantern Pharma Inc
NASDAQ
2.820
+0.110
+4.06%
After Hours: 2.820 0 0.00% 16:04 03/04 EST
OPEN
2.750
PREV CLOSE
2.710
HIGH
2.850
LOW
2.700
VOLUME
17.46K
TURNOVER
--
52 WEEK HIGH
5.74
52 WEEK LOW
2.450
MARKET CAP
31.54M
P/E (TTM)
-1.6089
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LTRN last week (0223-0227)?
Weekly Report · 2d ago
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 02/25 21:07
Weekly Report: what happened at LTRN last week (0216-0220)?
Weekly Report · 02/23 09:15
Weekly Report: what happened at LTRN last week (0209-0213)?
Weekly Report · 02/16 09:16
Lantern Pharma Announces Availability of 2024 Annual Report
Reuters · 02/10 13:45
Lantern Pharma to Present at the 7th Glioblastoma Drug Development Summit in Boston on February 17-19, 2026
Barchart · 02/10 07:45
Weekly Report: what happened at LTRN last week (0202-0206)?
Weekly Report · 02/09 09:16
Weekly Report: what happened at LTRN last week (0126-0130)?
Weekly Report · 02/02 09:16
More
About LTRN
Lantern Pharma Inc. is an artificial intelligence (AI) company. The Company is developing cancer therapies and transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, leverages over 100 billion oncology-focused data points and a library of over 200+ advanced ML algorithms to help solve problems in oncology drug development. It is engaged in the development of its pipeline of therapies that span multiple cancer indications, including both solid tumors and blood cancers and an antibody drug conjugate (ADC) program. It has active clinical programs for its three lead small molecule drug candidates: LP-300, LP-184, and LP-284. These programs are focused on multiple cancer indications, including both solid tumors and blood cancers. It is also focused on the clinical execution of its therapies for CNS and brain cancers through Starlight Therapeutics Inc.

Webull offers Lantern Pharma Inc stock information, including NASDAQ: LTRN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LTRN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LTRN stock methods without spending real money on the virtual paper trading platform.